On December 29, 2022, the Consolidated Appropriations Act of 2023 (CAA 2023) established a new requirement for all DEA-registered practitioners to complete 8 hours of training on the treatment and management of patients with opioid or other substance use disorders. As an accredited organization named in section 1263 of CAA 2023, ASAM offers a wide variety of education that meets the needs of all prescribers; from basics to advanced topics on addiction treatment, relevant to all specialties in all care settings.
For additional information, visit: https://www.asam.org/education/dea-education-requirements?utm_medium=email&utm_campaign=DEA%20Waiver%20Announcement&utm_content=DEA%20Waiver%20Announcement+CID_a06cb3eea78833185ded69d3b8b670ef&utm_source=Email%20Campaign%20Monitor&utm_term=Review%20Guidance%20%20Details